Day: July 19, 2022

Park Street A/S Company announcement Conversion of class B shares into listed class A shares With reference to company announcements of 25 April 2022 and 1 April 2022, Park Street A/S hereby announces that conversion of 2,137,939 class B shares of nominal value DKK 1.00 into 2,137,939 class A shares with nominal value DKK 1.00 held by Park Street NordAc S.a.r.l. to be admitted to trading and listed on Nasdaq Copenhagen has now been completed with the Danish Business Authority. The 2,137,939 class A shares are expected to be listed on Nasdaq Copenhagen with effect from 20 July 2022. As the shares represent less than 20 % of the company’s class A share capital already admitted to trading and listed on Nasdaq Copenhagen, no prospectus has been prepared by the company in connection with the conversion pursuant to an exemption from the...

HAMPTON, N.H., July 19, 2022 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its second quarter 2022 earnings before the market opens on August 2, 2022. Unitil will host its conference call and webcast later that day at 10:00 a.m. (ET) to review its quarterly results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably delivering natural gas...

Company AnnouncementNet sales of DARZALEX® in the second quarter of 2022 totaled USD 1,986 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen)COPENHAGEN, Denmark; July 19, 2022 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX® (daratumumab), including sales of the subcutaneous (SC) formulation (daratumumab and hyaluronidase-fihj, sold under the tradename DARZALEX FASPRO® in the U.S.), as reported by Johnson & Johnson were USD 1,986 million in the second quarter of 2022. Net trade sales were USD 1,021 million in the U.S. and USD 965 million in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC formulations, under the exclusive worldwide license to Janssen to develop, manufacture and commercialize...

Company will also begin pursuing strategic investments in complementary technologies SANTA BARBARA, CA, July 19, 2022 (GLOBE NEWSWIRE) — SunHydrogen, Inc. (OTC: HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, today shared an update detailing the Company’s financial position following the completion of the 2022 fiscal year on June 30. SunHydrogen reports a financial position of $52 million in cash and cash equivalents on its balance sheet as of June 30, 2022, a number that instills confidence in its executive and scientific teams alike as the Company continues moving toward the commercialization of its nanoparticle-based green hydrogen technology. SunHydrogen is currently at a critical developmental juncture with the goal of a production-quality prototype set for the end...

All amounts expressed in US dollars QUETTA, Pakistan., July 19, 2022 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) – Barrick president and chief executive Mark Bristow said today the Reko Diq copper-gold project, a partnership between the company, the Balochistan Provincial Government and Pakistani state-owned enterprises, would create substantial value for the province through multiple generations. Speaking after his meeting here today with Balochistan chief minister Abdul Quddus Bizenjo, Bristow said that in the negotiations Barrick and the Government of Pakistan had worked to ensure that Balochistan will receive a substantial share of the benefits generated by Reko Diq. “Balochistan’s shareholding in Reko Diq will be fully funded by its partners and the federal government, which means that the province will...

The Supervisory Board of AS Harju Elekter decided to increase the share capital of the company by 170,700.39 euros by issuing new ordinary shares. The increase of the share capital was triggered by the need to issue new shares to the key persons of Harju Elekter Group, incl. the members of the governing bodies, leading specialists, and engineers, participating in the option program approved with the resolution of the general meeting on 3 May 2018. A total of 75 current and former employees of Harju Elekter participated in the issue of AS Harju Elekter shares total of 270,953 shares for a total of 1,078,392.94 euros. A total of 26,247 shares were not subscribed. Decisions of the Supervisory Board of AS Harju Elekter:Harju Elekter’s share capital will be increased by a maximum of 170,700.39 euros, i.e., from 11,351,689.65 euros to...